EPF’s reaction to the European Parliament’s position on the revision of the EU pharmaceutical legislation

The European Patients' Forum (EPF) welcomes the European Parliament's adoption of the reports on the Directive and the Regulation, formalising the Parliament's official position on the revision of the EU pharmaceutical legislation.

The revision represents a unique opportunity to prioritise patients' needs by increasing their involvement throughout the medicine lifecycle and improving their access to safe, effective, and high-quality medicines.

This landmark agreement brings us closer to achieving a more patient-centred EU pharmaceutical regulatory framework. We look forward to working with the Council of the EU to embed the Parliament’s improvements and include additional amendments to ensure that the revision truly meets patients’ needs.

Read our statement here.